Your browser doesn't support javascript.
A study of clinical profile of Multi Inflammatory Syndrome Child (MIS-C) patients from 1 month to 12 years admitted to paediatric ward in a tertiary care centre in Western Maharashtra
Current Pediatric Research ; 26(5):1346-1350, 2022.
Article in English | EMBASE | ID: covidwho-2081556
ABSTRACT

Background:

Multisystem Inflammatory Syndrome-Child (MIS-C) is a rare but life-threatening complication of COVID-19 in children. Objective(s) To study clinical profile of patients with MIS-C in pediatric ward in a tertiary care centre in Western Maharashtra Study

design:

Observational study

Participants:

Patients satisfying MIS-C criteria by WHO during the study period

Results:

3.1 % (23 cases) of the total admissions during the study period in the pediatric ward were cases of MIS-C. The median age of MIS-C cases was 5 years (1.5 months to 12 years). Out of 23 cases, 10 cases were with shock, 7 cases without shock and 6 cases were of Kawasaki phenotype. They were treated with steroids alone, steroids plus IVIG or only symptomatic treatment. There was mortality in 1 patient (4.3%). Conclusion(s) Steroids and IVIG can be lifesaving in MIS-C cases if diagnosed early and given prompt treatment. Copyright © 2022 Scientific Publishers of India. All rights reserved.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Current Pediatric Research Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Current Pediatric Research Year: 2022 Document Type: Article